CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical Characteristics of Allergy to a Brinzolamide 1.0%/Brimonidine 0.2% Fixed Combination in Korean Glaucoma Patients
In Ki Park, Seon Ha Bae, Kyoung Woo Kim, Yeoun Sook Chun
J Korean Ophthalmol Soc. 2020;61(9):1065-1071.   Published online September 15, 2020
DOI: https://doi.org/10.3341/jkos.2020.61.9.1065

Excel Download

Clinical Characteristics of Allergy to a Brinzolamide 1.0%/Brimonidine 0.2% Fixed Combination in Korean Glaucoma Patients
Journal of the Korean Ophthalmological Society. 2020;61(9):1065-1071   Crossref logo
Link1 Link2 Link3

Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension
Clinical Ophthalmology. 2013;1053   Crossref logo
Link1

Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension
Clinical Ophthalmology. 2015;2201   Crossref logo
Link1

The Efficacy of Brinzolamide 1%/Brimonidine 0.2% Fixed Combination in Normal Tension Glaucoma
Journal of the Korean Ophthalmological Society. 2016;57(10):1619   Crossref logo
Link1 Link2 Link3

Clinical Effectiveness of a Brinzolamide 1%-Brimonidine 0.2% Fixed Combination for Normal Tension Glaucoma in South Koreans
Journal of the Korean Ophthalmological Society. 2018;59(6):561   Crossref logo
Link1 Link2 Link3

Fixed-combination brinzolamide 1%/brimonidine 0.2% vs monotherapy with brinzolamide or brimonidine in patients with open-angle glaucoma or ocular hypertension: results of a pooled analysis of two phase 3 studies
Eye. 2013;27(7):841-847   Crossref logo
Link1 Link2 Link3

Comparison of Allergy Prevalence between Brimonidine/Timolol Fixed Combination and 0.15% Brimonidine in Glaucoma Patients
Journal of the Korean Ophthalmological Society. 2018;59(5):451   Crossref logo
Link1 Link2 Link3

Twice-Daily Brinzolamide/Brimonidine Fixed Combination versus Brinzolamide or Brimonidine in Open-Angle Glaucoma or Ocular Hypertension
Ophthalmology. 2014;121(12):2348-2355   Crossref logo
Link1 Link2

Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension

Clinical Ophthalmology. 2020;Volume 14:221-230   Crossref logo
Link1 Link2

Twice-Daily 0.2% Brimonidine-0.5% Timolol Fixed-Combination Therapy vs Monotherapy With Timolol or Brimonidine in Patients With Glaucoma or Ocular Hypertension: A 12-Month Randomized Trial
Yearbook of Ophthalmology. 2007;2007:70-71   Crossref logo
Link1 Link2